Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Paramount Bed Holdings Co's EBIT per Share for the
three
months ended in Sep. 2025 was 円36.92.
Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2025 was 円60.22.
During the past 12 months, the average EBIT per Share Growth Rate of Paramount Bed Holdings Co was -56.60% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 2.30% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 6.40% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 4.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Paramount Bed Holdings Co's EBIT per Share or its related term are showing as below:
TSE:7817'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -40.7 Med: 4.35 Max: 78.1
Current: 2.3
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Paramount Bed Holdings Co was 78.10% per year. The lowest was -40.70% per year. And the median was 4.35% per year.
TSE:7817's 3-Year EBIT Growth Rate is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 9.6
vs TSE:7817: 2.30
Paramount Bed Holdings Co (TSE:7817) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Paramount Bed Holdings Co EBIT per Share Related Terms
Paramount Bed Holdings Co EBIT per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円60.22
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Paramount Bed Holdings Co (TSE:7817) has a EBIT per Share of 円60.22 as of Sep. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Paramount Bed Holdings Co and its competitors.
Is Paramount Bed Holdings Co's EBIT per Share too high?
Paramount Bed Holdings Co's current EBIT per Share is 円60.22. Overall, Paramount Bed Holdings Co has a GF Score™ of 69/100, reflecting its overall financial health beyond just this single metric.
How does Paramount Bed Holdings Co's EBIT per Share compare to ISRG and BDX?
Paramount Bed Holdings Co's EBIT per Share of 円60.22 can be compared against companies in the Medical Devices & Instruments industry. The industry median EBIT per Share is 9.60. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Devices & Instruments company?
The median EBIT per Share among Medical Devices & Instruments companies is 9.60, based on 685 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Paramount Bed Holdings Co and its competitors. For the Medical Devices & Instruments industry, the median EBIT per Share is 9.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Paramount Bed Holdings Co's current EBIT per Share is 円60.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Paramount Bed Holdings Co stock overvalued right now?
Paramount Bed Holdings Co (TSE:7817) has a current EBIT per Share of 円60.22. The stock's GF Value™ is 円2,907.43, compared to a current price of 円3,515.00 — trading 20.9% above its estimated fair value. The current EBIT per Share is 円60.22. Paramount Bed Holdings Co's overall GF Score™ is 69/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Paramount Bed Holdings Co (TSE:7817), the current EBIT per Share is 円60.22 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Paramount Bed Holdings Co (TSE:7817) Overvalued in 2026?
Based on GuruFocus' analysis, Paramount Bed Holdings Co stock appears to be overvalued.
The current stock price of 円3,515.00 is trading 20.9% above its estimated GF Value™ of 円2,907.43.
Key valuation signals for TSE:7817:
EBIT per Share: 円60.22
GF Value™: 円2,907.43 vs. price of 円3,515.00 (20.9% above fair value)
No single metric tells the full story. See the TSE:7817 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Paramount Bed Holdings Co Ltd manufactures medical and nursing care products. Its acute care business sells products to intensive care units and other acute care facilities to relieve patient discomfort and prevent secondary infections. The long-term care business sells products used at long-term medical care facilities and nursing homes. The residential and nursing care business sells products to nurses and home-care helpers. The sleep and wellness business sells products to help customers sleep soundly, which include custom-made mattresses. The maintenance business provides bed maintenance and cleaning services. Paramount Bed generates the vast majority of its revenue in Japan.
69GF Score
Get the complete analysis for TSE:7817
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7817 has been successfully added to your 
